Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Elliott Dasenbrook, M.D., MHS
Case Western Reserve University School of Medicine and Rainbow Babies and Children's Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
38 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Pulmonary Associates of Mobile
Mobile, Alabama, United States
- University of Arkansas for Medical Science
Little Rock, Arkansas, United States
- Children'S Hospital Los Angeles, Division of Pediatric Pulmonology
Los Angeles, California, United States
- National Jewish Health
Denver, Colorado, United States
- Joe Dimaggio Children'S Hospital
Hollywood, Florida, United States
- University of Miami - Miller School of Medicine
Miami, Florida, United States
- Central Florida Pulmonary Group
Orlando, Florida, United States
- Nemours Children'S Clinic and Hospital
Orlando, Florida, United States
- New Lung Associates, Pa; Lung Transplant, Adult Cystic Fibrosis, and the Center for Advanced Lung Diseases, Tampa General Hospital
Tampa, Florida, United States
- Ann & Robert H. Lurie Children'S Hospital of Chicago
Chicago, Illinois, United States
- Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
- the Cystic Fibrosis Center of Chicago
Glenview, Illinois, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- University of Kentucky Cystic Fibrosis Clinic
Lexington, Kentucky, United States
- University of Louisville
Louisville, Kentucky, United States
- Boston Children'S Hospital Cystic Fibrosis Center
Boston, Massachusetts, United States
- Massachusetts General Hospital Pediatric Cystic Fibrosis Center
Boston, Massachusetts, United States
- Wayne State University, Harper Hospital, Children'S Hospital of Michigan
Detroit, Michigan, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Rutgers Robert Wood Johnson Medical School
New Brunswick, New Jersey, United States
- Hofstra North Shore - Long Island Jewish School of Medicine
New Hyde Park, New York, United States
- Columbia University Medical Center
New York, New York, United States
- University of North Carolina
Chapel Hill, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Rainbow Babies and Children'S Hospital / University Hospitals Case Medical Center
Cleveland, Ohio, United States
- Nationwide Children'S Hospital
Columbus, Ohio, United States
- the Children'S Medical Center of Dayton
Dayton, Ohio, United States
- Santiago Reyes, Md
Oklahoma City, Oklahoma, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Children'S Hospital of Pittsburgh of Upmc
Pittsburgh, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- Dell Children'S Medical Center of Central Texas
Austin, Texas, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
- Baylor College of Medicine and Texas Children'S Hospital
Houston, Texas, United States
- University of Texas Health Science Center at Tyler
Tyler, Texas, United States
- University of Utah, Intermountain Cystic Fibrosis Center
Salt Lake City, Utah, United States
- University of Washington Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2013
- Primary completion
- 30 Nov 2014
- Completion
- 30 Nov 2014
- Last update posted
- 13 Jan 2020
- Registered enrollment
- 87
- Registry id
- NCT01746095
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.